US equities |
MU $1,046.60 ▼-1.74% NVDA $229.95 ▲+0.69% SNDK $1,731.80 ▼-0.47% TSLA $356.82 ▲+0.57% INTC $119.33 ▼-0.75% AMD $608.64 ▼-0.51% GOOGL $341.10 ▼-0.87% LITE $1,063.42 ▲+9.49%
FinancialContent Watchlist

Articles published by Mirum Pharmaceuticals

News headline image
Mirum’s LIVMARLI® Now Authorized in Canada for Cholestatic Pruritus in Patients with Alagille Syndrome
From Mirum Pharmaceuticals
Via Business Wire
Tickers MIRM